Skip to main content

Free Fertility App Shared Info With Third Parties, FTC Says

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

THURSDAY, May 18, 2023 -- Owners of the free fertility app Premom have settled with users after sharing health data without consent to other companies, including Google and marketing firms in China.

The U.S. Federal Trade Commission (FTC) announced the $200,000 settlement with Premom owner Easy Healthcare.

"Premom broke its promises and compromised consumers' privacy," said Samuel Levine, director of the FTC's Bureau of Consumer Protection.

"We will vigorously enforce the Health Breach Notification Rule to defend consumer's health data from exploitation," he said in an FTC news release. "Companies collecting this information should be aware that the FTC will not tolerate health privacy abuses."

As part of a proposed settlement, the company agreed to a $100,000 civil penalty and another $100,000 to be paid to Connecticut, Oregon and the District of Columbia, for violating their laws.

Hundreds of thousands of users use the free app to track ovulation, menstrual periods and other health information. The app encourages users to provide information about their cycles, fertility and pregnancy and to import data from other apps such as Apple Health, the FTC said.

It said the company shared data for advertising purposes without disclosing this to users, getting their permission or limiting how that information could be used.

"The data it shared with third parties revealed highly sensitive and private details about Premom’s users and led to the unauthorized disclosure of facts about an individual user’s sexual and reproductive health, parental and pregnancy status, as well as other information about physical health conditions and status," the FTC said.

The U.S. Department of Justice filed a proposed court order Wednesday on behalf of the FTC.

As part of that order, Easy Healthcare would be barred from sharing users' personal health data with third parties for advertising. It would also be required to obtain users' consent before sharing health data for any other purpose and must tell consumers how their personal data will be used, the FTC said. The proposed order must be approved by the federal court to go into effect.

Sharing of private fertility information has become more of a concern since the U.S. Supreme Court overturned Roe v. Wade.

Easy Healthcare did not admit wrongdoing, CBS News reported.

"Rather, it is a settlement to avoid the time and expense of litigation and enables us to put this matter behind us and focus on you, our users," the company wrote in a statement on the Premom website. "Rest assured that we do not, and will not, ever sell any information about users' health to third parties, nor do we share it for advertising purposes."

While the Health Insurance Portability and Accountability Act, better known as HIPAA, protects medical privacy in health care settings, that doesn’t carry over to information individuals provide to tech companies, CBS News reported.

Sources

  • CBS News
  • FTC, news release, May 17, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Feds Announce New Measures to Monitor, Prevent Bird Flu

FRIDAY, May 10, 2024 -- H5N1 avian flu is now infecting U.S. dairy cows and the federal government on Friday announced a myriad of initiatives aimed at preventing the virus'...

His Cancer Journey Shows Health Dangers Firefighters Face

FRIDAY, May 10, 2024 -- For 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. Then a routine physical turned up anomalies in his blood...

Baby Girl Born Deaf Gains Hearing After Gene Therapy

FRIDAY, May 10, 2024 -- Opal Sandy was born into a world she could not hear.  The British baby girl, now 18 months old, had a rare genetic condition called auditory...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.